HITAP and COVID-19
HITAP is conducting COVID-19 related research to support policy decision to combat COVID-19.
This will benefit not only in Thailand but also other countries globally,
which share the same concerns.
Developing protocols for rationing scarce critical-care resources (intensive care unit (ICU) beds and ventilators) during the COVID-19 pandemic in Thailand
Covid-19 outbreak poses a threat to the public health worldwide. In Thailand, while the case number is continued to surge, the critical-care resources are scarce,
and there is no specific drug or vaccination available for this disease.
HITAP in collaboration with IHPP are developing a protocol for rationing criteria of scarce resources (ICU beds and ventilators).
This work will not only support the healthcare professionals, public health bodies and policymaker in Thailand making a fair, transparent and ethically appropriate allocation decision, it also help relieve the moral stress upon bedside physicians when resources become limited under a public health emergency.
COVID-19 put a pressure on both physical and mental health.
It causes stress and anxiety, and changes lives of people around the world.
How can we maintain both physical and mental health through this situation?
Impact and Policy
COVID-19 hits more than half of the world and kills many lives. Policy is warranted to tackle this, and this may affect both people and the country as a whole. How COVID-19 and related policies affect people and how to contain the unneeded spillover? Exploring these issues will take us through this together.
Treatment and Health System
Vaccines and medicines is the hope in battling COVID-19. Until the day we have them arrives, health system need to be deal with the disease with whatever resources available. How is COVID-19 being treated? Are health systems still doing fine? If not, what is up next.
There are a lot of unknowns about COVID-19, and more information is released everyday. HITAP will pick some interesting topics and share here.
FAQ about COVID-19
When and how will COVID-19 pandemic end?
COVID-19 pandemic may end in 2 ways.
- Vaccines - Need at least 12-18 months for the trials to complete. If at least 60% of population is immunised, herd immunity effect will prevent further infection of COVID-19.
- Natural immunity - Need at least 2 years. In case no vaccines are available, those infected will develop immunity to create herd effect and prevent further spread of the disease.
However, there is the third possibility that there is not clear endpoint for the pandemic, and some measures to tackle COVID-19 will continue to be in place. However, a permanent change in people's behaviour and hygiene will slow the spread.
Source: BBC, 25 March 2020 https://www.bbc.com/news/health-51963486
For Public Health Personnel
What are the potential drugs to treat COVID-19
There are 4 main groups of treatments including drugs that researchers are investigating in clinical trials.
- Anti-viral drugs, e.g. remdesivir, lopinavir/ritonavir
- Antimalarial drugs, i.e. chloroquine and hydroxychloroquine
- Immunosuppressor or immunomodulator, e.g. tocilizumab
- Mesenchymal stem cells and plasma
On April 17, 2020 National Institute of Health, US, announced that a study in animal found that remdesivir can prevent disease progress, and there are many ongoing clinical trials on this drug.
COVID-19 is a new disease about which mankind knows so little. There are many questions to be answered, and some answers are listed here.